Breaking News

Braving the big, bad B word

With Brexit looming, what can industry do to prepare?

Issues, developments and the future of primary packaging

Dan Stehn, Director of Injectable Packaging at Sharp, comments on the rise of complex packaging projects

Pharmapack predicts future European drug delivery and packaging trends

Report by the pharmaceutical event has predicted diversification of innovation leading to a rise in licensing and ...

Broad stripes, bright stars and a thriving pharmaceutical industry: part II

According to one of Stephen Sondheim’s most well-known lyrics, “I like to be in America! OK by me in America!” ...

The rise of fake news in science

Why pay and play publishing is not right for you, your customers or the scientific community

British manufacturing in 2019

The UK is predicted to break back into the top five manufacturing nations

Broad stripes, bright stars and a thriving pharmaceutical industry: part I

According to one of Stephen Sondheim’s most well-known lyrics, “I like to be in America! OK by me in America!” ...

Eli Lilly’s acquisition of Loxo Oncology will result in quick return of investment

Eli Lilly’s acquisition of Loxo Oncology marks the second multibillion-dollar deal in 2019 following the recent BMS ...

BMS' acquisition of Celgene could position the company amongst top five most profitable pharma giants

Following the Bristol-Myers Squibb (BMS) announcement on 3 January 2019 that it will acquire Celgene in a cash and ...

Connecting the dots in digital health

In this feature, Phillips-Medisize, a Molex company, looks at the potential of smart devices and connected health ...

Developments and the future of pharmaceutical packaging

With the global primary packaging market in the pharmaceutical sector expected to experience remarkable growth during ...

Moving the needle in 2019

By now, says 3M’s Dr Steven Wick, it’s no secret that technological advances are changing the landscape of drug ...

Drug pricing and reimbursement concerns will remain the leading impediment to industry growth in 2019

In 2019, drug pricing pressure from regulators, patients, politicians and payers will remain and aggressive negotiation ...

R&D returns fall to lowest level in 9 years, says Deloitte and GlobalData

Projected returns on investment in research and development (R&D) for the top 12 biopharmaceutical companies have ...